NRF1 and cancer: The mechanisms thought to confer PI resistance to cancer cells include the upregulation of Nrf1, a transcription factor that increases the expression of proteasome subunits, and the formation of aggresome, which allows cells to escape proteotoxicity by sequestering toxic cellular aggregates [30,31].